Capital International, Inc. Eli Lilly & CO Transaction History

Capital International, Inc.

$7.11 Billion
Q1 2024

A detailed history of Capital International, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital International, Inc. holds 128,908 shares of LLY stock, worth $113 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

128,908

Previous 139,114 7.34%

Holding current value

$113 Million

Previous $81.1 Million 23.67%

% of portfolio

1.41%

Previous 1.31%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $6.04 Million - $8.09 Million	-10,206 Reduced 7.34%	128,908 $100 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $14.6 Million - $17.2 Million	27,727 Added 24.89%	139,114 $81.1 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2.13 Million - $2.94 Million	4,903 Added 4.6%	111,387 $59.8 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $6.91 Million - $9.24 Million	19,712 Added 22.72%	106,484 $49.9 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $2.12 Million - $2.49 Million	-6,824 Reduced 7.29%	86,772 $29.8 Million

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $988,123 - $1.15 Million	-3,073 Reduced 3.18%	93,596 $34.2 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $7.71 Million - $8.79 Million	-26,004 Reduced 21.2%	96,669 $31.3 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $10.5 Million - $12.4 Million	37,796 Added 44.53%	122,673 $39.8 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $141,048 - $175,287	601 Added 0.71%	84,877 $24.3 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2.05 Million - $2.54 Million	9,120 Added 12.13%	84,276 $23.3 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $3.19 Million - $3.93 Million	-14,402 Reduced 16.08%	75,156 $17.4 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $637,160 - $824,162	-3,529 Reduced 3.79%	89,558 $20.6 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $10.2 Million - $13.2 Million	61,865 Added 198.15%	93,087 $17.4 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $1.87 Million - $2.47 Million	-14,334 Reduced 31.46%	31,222 $5.27 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $765,023 - $884,888	-5,232 Reduced 10.3%	45,556 $6.74 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $43.1 Million - $51.8 Million	-315,740 Reduced 86.14%	50,788 $8.34 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $507,986 - $628,742	-4,267 Reduced 1.15%	366,528 $50.8 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $1.3 Million - $1.61 Million	-12,192 Reduced 3.18%	370,795 $48.7 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $39.1 Million - $42.5 Million	366,155 Added 2175.35%	382,987 $42.8 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $813,530 - $949,596	-7,343 Reduced 30.37%	16,832 $1.87 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $537,627 - $632,826	-4,830 Reduced 16.65%	24,175 $3.14 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $201,951 - $226,246	-1,907 Reduced 6.17%	29,005 $3.36 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $1.21 Million - $1.52 Million	14,122 Added 84.11%	30,912 $3.32 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $14,841 - $17,520	200 Added 1.21%	16,790 $1.3 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $375,694 - $402,975	4,585 Added 38.19%	16,590 $1.4 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $925,225 - $1.03 Million	12,005	12,005 $1.03 Million

Others Institutions Holding LLY

# of Institutions

3,749

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $835B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Eli Lilly & CO Transaction History